StreetAlpha
Bright Minds Biosciences Inc. · 13F filings

DRUG Institutional Ownership

Holdings as of Sep 30, 2026From SEC Form 13FUpdated

Who owns Bright Minds Biosciences Inc. and what the big funds did with it last quarter, from every SEC 13F filing. 110 funds reported holding DRUG at Sep 30, 2026.

← DRUG stock page

Who owns the most DRUG

shares · value · change
  1. 1Janus Henderson Group Ltd.1.3M sh$67M–
  2. 2Cormorant Asset Management, LP800K sh$39.9M−100K
  3. 3BlackRock, Inc.652K sh$32.5M−34K
  4. 4Vestal Point Capital, LP545K sh$27.2M0
  5. 5Braidwell LP484K sh$24.1M0
Biggest move: Seven Grand Managers sold 120K shares (−$8.4M).See all top holders ↓
Free account: all 25 DRUG holders, every new DRUG 13F filing as it lands, and each fund’s full portfolio. Create free accountSign in
AI Pro · stock alerts

Get an alert when the big funds move DRUG

13F season runs for 45 days after each quarter. We watch every filing and tell you the moment a superinvestor or one of DRUG’s top 25 holders buys, sells or exits (moves of 5% or more), by email or on your phone.

Stock alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

What an alert looks like
Seven Grand Managers cut DRUG by 120K sharesQ3 2026 13F · −$8.4M
Morgan Stanley added to DRUG by 69K sharesQ3 2026 13F · +$3.4M
Real DRUG moves from last quarter’s filings. Alerts come from public SEC 13F filings and are not investment advice.
Fund sentiment
Neutral
Strongly bearishNeutralStrongly bullish
  • ●45 buying vs 46 selling
  • ▼Shares held by funds -3.4%
  • ▲Funds holding +10
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful

What the filings show, not a forecast. Positions can be up to 45 days old and leave out short sales.

Funds holding110+10 vs Q2 2026
Held by funds–of shares outstanding
Value held$448M9M shares
Put/call ratio–market makers left out

Funds holding and ownership

8 quarters
Q4 2024: 31 fundsQ4 '24Q1 2025: 34 fundsQ1 '25Q2 2025: 47 fundsQ2 '25Q3 2025: 64 fundsQ3 '25Q4 2025: 74 fundsQ4 '25Q1 2026: 94 fundsQ1 '26Q2 2026: 100 fundsQ2 '26Q3 2026: 110 fundsQ3 '26
Funds holding

Quarter over quarter

all 13F filers
Q3 2026This quarterQ2 2026Change
Funds holding110100+10.0%
In funds' top 1012−50.0%
13F shares9M9.3M−3.4%
Held by funds–––
New positions1719−10.5%
Increased2847−40.4%
Reduced3817+123.5%
Sold out812−33.3%
Calls (shares)00–
Puts (shares)00–
Put/call ratio–––

Buyers vs sellers

adding or new vs cutting or sold out
Q1 2025: 20 buyingQ1 2025: 15 sellingQ1 '25Q2 2025: 29 buyingQ2 2025: 18 sellingQ2 '25Q3 2025: 40 buyingQ3 2025: 14 sellingQ3 '25Q4 2025: 44 buyingQ4 2025: 27 sellingQ4 '25Q1 2026: 71 buyingQ1 2026: 22 sellingQ1 '26Q2 2026: 66 buyingQ2 2026: 29 sellingQ2 '26Q3 2026: 45 buyingQ3 2026: 46 sellingQ3 '26
Buying 45Selling 46latest quarter

Superinvestors in DRUG

All superinvestors →

Who owns DRUG

share of fund held shares
  • Index and passive funds11.0%
  • Active managers and hedge funds84.7%
  • Banks and brokers4.1%
  • Pensions, insurers and other0.2%

The top 10 holders own 63.3% of all DRUG shares that funds reported. Groups are our own grouping of filers by name.

Top holders

Q3 2026
#FundOf companySharesValueChange
1Janus Henderson Group Ltd.–1.3M$67M–
2Cormorant Asset Management, LP–800K$39.9M−100K
3BlackRock, Inc.–652K$32.5M−34K
4Vestal Point Capital, LP–545K$27.2M0
5Braidwell LP–484K$24.1M0
6Driehaus Capital Management LLC–445K$22.2M+12K
7Vivo Capital, LLC–418K$20.8M−139K
8Point72 Asset Management, L.P.–372K$18.6M+45K
9Adage Capital Partners Gp, L.l.c.–325K$16.2M−10K
10Balyasny Asset Management L.P.–305K$15.2M−40K
🔒 15 more top holders. Create a free account or sign in to see them.
Biggest buyers
Biggest sellers

DRUG institutional ownership FAQ

Who owns the most DRUG stock?

In Q3 2026 13F filings the largest holder of DRUG was Janus Henderson Group Ltd., followed by Cormorant Asset Management, LP and BlackRock, Inc.. Index fund managers are usually the biggest holders of large companies.

What percentage of DRUG is owned by institutions?

110 funds reported holding 9M DRUG shares at Sep 30, 2026.

Are hedge funds buying DRUG?

In Q3 2026, 45 funds bought DRUG (17 of them new positions) and 46 sold (8 sold out completely). Among well known investors, 2 added and 1 cut. Our fund sentiment for DRUG is neutral.

What is DRUG's institutional put/call ratio?

Too few option positions were reported for a meaningful ratio.

How current is this DRUG ownership data?

13F filings show holdings at the end of each quarter and are due within 45 days, so positions can be up to six weeks old when they appear. We add each new filing within minutes, and the "filed so far" list shows funds that have already reported the next quarter.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Fund sentiment summarises what 13F filings show and is not a forecast. Holdings come from SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.